Allograft vasculopathy: a 23-year retrospective analysis from the Large Lifelink Transplant Registry




Background


Coronary allograft vasculopathy (CAV) is a major cause of mortality in heart transplantation. Immunosuppressants, coronary risk factors, and statins may influence its pathogenesis. There are conflicting reports regarding the benefits of drug-eluting stents (DES) over bare metal stents (BMS) in CAV.




Methods


We retrospectively analyzed a large, single-center (Lifelink) transplant registry for CAV patients undergoing percutaneous coronary intervention (PCI) and evaluated different clinical, percutaneous revascularization, and outcome variables including time trends.




Methods


We retrospectively analyzed a large, single-center (Lifelink) transplant registry for CAV patients undergoing percutaneous coronary intervention (PCI) and evaluated different clinical, percutaneous revascularization, and outcome variables including time trends.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Editorial Note
  2. Acute type A aortic dissection in a patient with ventricular septal defect
  3. Adverse outcomes in patients prescribed a proton pump inhibitor following percutaneous coronary intervention with drug-eluting stents
  4. Decreasing trend in in-hospital mortality of patients undergoing percutaneous coronary intervention regardless of race or gender with persistent higher mortality rates in women and minorities in the United States

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Allograft vasculopathy: a 23-year retrospective analysis from the Large Lifelink Transplant Registry

Full access? Get Clinical Tree
Get Clinical Tree app for offline access